Brandeau ML - Search Results

1

Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, Chen JH, Cuéllar MF, Hurd YL, Juurlink DN, Koh HK, Krebs EE, Lembke A, Mackey SC, Larrimore Ouellette L, Suffoletto B, Timko C. Humphreys K, et al. Among authors: brandeau ml. Lancet. 2022 Feb 5;399(10324):555-604. doi: 10.1016/S0140-6736(21)02252-2. Epub 2022 Feb 2. Lancet. 2022. PMID: 35122753 Free PMC article. Review. No abstract available.

2

Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic.

Pitt AL, Humphreys K, Brandeau ML. Pitt AL, et al. Among authors: brandeau ml. Am J Public Health. 2018 Oct;108(10):1394-1400. doi: 10.2105/AJPH.2018.304590. Epub 2018 Aug 23. Am J Public Health. 2018. PMID: 30138057 Free PMC article.

3

Cost-effectiveness of Treatments for Opioid Use Disorder.

Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. Fairley M, et al. Among authors: brandeau ml. JAMA Psychiatry. 2021 Jul 1;78(7):767-777. doi: 10.1001/jamapsychiatry.2021.0247. JAMA Psychiatry. 2021. PMID: 33787832 Free PMC article.

4

Effectiveness of Policies for Addressing the US Opioid Epidemic: A Model-Based Analysis from the Stanford-Lancet Commission on the North American Opioid Crisis.

Rao IJ, Humphreys K, Brandeau ML. Rao IJ, et al. Among authors: brandeau ml. Lancet Reg Health Am. 2021 Nov;3:100031. doi: 10.1016/j.lana.2021.100031. Epub 2021 Jul 31. Lancet Reg Health Am. 2021. PMID: 34790907 Free PMC article.

5

Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder.

Qian G, Rao I, Humphreys K, Owens DK, Brandeau ML. Qian G, et al. Among authors: brandeau ml. Drug Alcohol Depend. 2023 Feb 1;243:109762. doi: 10.1016/j.drugalcdep.2022.109762. Epub 2022 Dec 30. Drug Alcohol Depend. 2023. PMID: 36621198 Free PMC article.

6

Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis.

Qian G, Humphreys K, Goldhaber-Fiebert JD, Brandeau ML. Qian G, et al. Among authors: brandeau ml. Drug Alcohol Depend. 2024 Mar 1;256:111112. doi: 10.1016/j.drugalcdep.2024.111112. Epub 2024 Feb 1. Drug Alcohol Depend. 2024. PMID: 38335797

7

Cost-effectiveness of alternative strategies for provision of HIV preexposure prophylaxis for people who inject drugs.

Fu R, Owens DK, Brandeau ML. Fu R, et al. Among authors: brandeau ml. AIDS. 2018 Mar 13;32(5):663-672. doi: 10.1097/QAD.0000000000001747. AIDS. 2018. PMID: 29334549 Free PMC article.

8

Responding to the US opioid crisis: leveraging analytics to support decision making.

Brandeau ML. Brandeau ML. Health Care Manag Sci. 2023 Dec;26(4):599-603. doi: 10.1007/s10729-023-09657-0. Epub 2023 Oct 7. Health Care Manag Sci. 2023. PMID: 37804456

9

Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.

Long EF, Brandeau ML, Galvin CM, Vinichenko T, Tole SP, Schwartz A, Sanders GD, Owens DK. Long EF, et al. Among authors: brandeau ml. AIDS. 2006 Nov 14;20(17):2207-15. doi: 10.1097/QAD.0b013e328010c7d0. AIDS. 2006. PMID: 17086061

10

The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA.

Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E. Juusola JL, et al. Among authors: brandeau ml. AIDS. 2011 Sep 10;25(14):1779-87. doi: 10.1097/QAD.0b013e328349f067. AIDS. 2011. PMID: 21716076 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page